Published in Proc Natl Acad Sci U S A on March 11, 2008
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe (2008) 2.81
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 2.22
Suppression of the antiviral response by an influenza histone mimic. Nature (2012) 2.18
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One (2010) 2.15
PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal (2010) 2.07
Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol (2009) 1.89
Virulence determinants of pandemic influenza viruses. J Clin Invest (2011) 1.87
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
H6 influenza viruses pose a potential threat to human health. J Virol (2014) 1.64
Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One (2009) 1.53
The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One (2011) 1.51
Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J Virol (2011) 1.48
Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 1.48
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res (2008) 1.47
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol (2009) 1.32
Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectors. J Gen Virol (2008) 1.29
The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol (2009) 1.29
Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J Virol (2010) 1.25
Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol (2013) 1.23
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One (2011) 1.21
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol (2009) 1.20
Antigenic and molecular characterization of avian influenza A(H9N2) viruses, Bangladesh. Emerg Infect Dis (2013) 1.19
Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol (2011) 1.17
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol (2010) 1.17
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J Gen Virol (2010) 1.16
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol (2010) 1.16
A Closer Look at the NS1 of Influenza Virus. Viruses (2009) 1.15
The first influenza pandemic of the new millennium. Influenza Other Respir Viruses (2011) 1.14
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol (2010) 1.13
Modification of nonstructural protein 1 of influenza A virus by SUMO1. J Virol (2010) 1.13
Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. J Virol (2011) 1.12
Novel influenza virus NS1 antagonists block replication and restore innate immune function. J Virol (2008) 1.11
Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J Virol (2008) 1.09
Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol (2010) 1.08
Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J (2011) 1.08
Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade. J Gen Virol (2014) 1.08
Avian influenza (H5N1) virus of clade 2.3.2 in domestic poultry in India. PLoS One (2012) 1.07
The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions. J Virol (2011) 1.07
Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China. PLoS One (2009) 1.06
Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J Virol (2009) 1.06
Host adaptation and transmission of influenza A viruses in mammals. Emerg Microbes Infect (2014) 1.06
Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog (2011) 1.03
Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection. PLoS One (2012) 1.01
Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. J Virol (2009) 1.01
The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Mol Biol Cell (2010) 1.01
Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice. PLoS Pathog (2010) 1.00
Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness. MBio (2014) 0.97
Towards a better understanding of the novel avian-origin H7N9 influenza A virus in China. Sci Rep (2013) 0.96
The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. MBio (2013) 0.96
Effects of the C-terminal truncation in NS1 protein of the 2009 pandemic H1N1 influenza virus on host gene expression. PLoS One (2011) 0.94
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways. J Gen Virol (2011) 0.92
Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J (2011) 0.91
2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs. J Virol (2011) 0.89
Determinants of virulence of influenza A virus. Eur J Clin Microbiol Infect Dis (2013) 0.89
Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol (2014) 0.89
Molecular characterization of the predominant influenza A(H1N1)pdm09 virus in Mexico, December 2011-February 2012. PLoS One (2012) 0.89
Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. J Virol (2013) 0.89
Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner. J Gen Virol (2010) 0.88
Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patients. J Virol (2012) 0.87
Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes. Virol J (2011) 0.87
PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy. Biomed Res Int (2013) 0.86
Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. Virus Res (2010) 0.85
Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1). J Virol (2010) 0.85
Proteome alterations in primary human alveolar macrophages in response to influenza A virus infection. J Proteome Res (2012) 0.85
Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res (2014) 0.84
Isolation and mutation trend analysis of influenza A virus subtype H9N2 in Egypt. Virol J (2012) 0.84
Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013. PLoS One (2015) 0.84
Evolutionarily conserved bias of amino-acid usage refines the definition of PDZ-binding motif. BMC Genomics (2011) 0.83
PDlim2 selectively interacts with the PDZ binding motif of highly pathogenic avian H5N1 influenza A virus NS1. PLoS One (2011) 0.83
Novel strategy to evaluate infectious salmon anemia virus variants by high resolution melting. PLoS One (2012) 0.83
Protein clustering and RNA phylogenetic reconstruction of the influenza A [corrected] virus NS1 protein allow an update in classification and identification of motif conservation. PLoS One (2013) 0.83
Genetic dynamic analysis of the influenza A H5N1 NS1 gene in China. PLoS One (2014) 0.82
Characterization of an artificial swine-origin influenza virus with the same gene combination as H1N1/2009 virus: a genesis clue of pandemic strain. PLoS One (2011) 0.82
Viral and host factors required for avian H5N1 influenza A virus replication in mammalian cells. Viruses (2013) 0.82
Adaption of seasonal H1N1 influenza virus in mice. PLoS One (2011) 0.82
H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice. Virology (2011) 0.81
Phylogenetics and pathogenesis of early avian influenza viruses (H5N1), Nigeria. Emerg Infect Dis (2008) 0.81
Fatal influenza A (H5N1) virus Infection in zoo-housed Tigers in Yunnan Province, China. Sci Rep (2016) 0.81
Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med (2014) 0.81
Comparative analysis of anti-viral transcriptomics reveals novel effects of influenza immune antagonism. BMC Immunol (2015) 0.81
The battle between influenza and the innate immune response in the human respiratory tract. Infect Chemother (2013) 0.80
The distinct binding properties between avian/human influenza A virus NS1 and Postsynaptic density protein-95 (PSD-95), and inhibition of nitric oxide production. Virol J (2011) 0.80
An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. Front Microbiol (2015) 0.80
Heterogeneous virulence of pandemic 2009 influenza H1N1 virus in mice. Virol J (2012) 0.80
Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets. Sci Rep (2015) 0.80
Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication. J Gen Virol (2011) 0.80
Genetic divergence of influenza A NS1 gene in pandemic 2009 H1N1 isolates with respect to H1N1 and H3N2 isolates from previous seasonal epidemics. Virol J (2010) 0.80
Genetic evolution of low pathogenecity H9N2 avian influenza viruses in Tunisia: acquisition of new mutations. Virol J (2011) 0.79
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 6.22
PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci (2001) 5.92
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell (1998) 5.60
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44
Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A (2001) 4.93
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol (2006) 4.88
Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A (2004) 4.00
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A (2006) 3.50
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94
IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol (2006) 2.93
NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol (2006) 2.78
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology (2007) 2.30
Retracted The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res (2004) 2.15
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14
The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc (2006) 1.96
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol (2004) 1.88
Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol (2007) 1.84
Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. Virus Res (2007) 1.77
The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology (1995) 1.74
Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis (2007) 1.61
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature (2006) 4.44
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
Gain-of-function experiments on H7N9. Science (2013) 3.67
The M2 proton channels of influenza A and B viruses. J Biol Chem (2005) 3.49
Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A (2009) 3.30
Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci U S A (2005) 3.25
The influenza virus gene pool in a poultry market in South central china. Virology (2003) 3.25
The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology (2002) 3.02
The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem (2002) 3.01
Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol (2002) 2.97
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
Influenza virus assembly and budding. Virology (2011) 2.90
Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol (2007) 2.89
Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A (2003) 2.83
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71
Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology (2007) 2.68
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63
Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure (2005) 2.47
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A (2010) 2.43
Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers. Protein Sci (2003) 2.43
Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2009) 2.32
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Pause on avian flu transmission research. Science (2012) 2.24
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology (2005) 2.17
Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2008) 2.15
Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol (2005) 2.15
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc Natl Acad Sci U S A (2006) 2.03
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol (2006) 2.01
A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol (2003) 2.00
Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol (2005) 1.88
Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology (2005) 1.85
GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med (2011) 1.83
Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J Virol (2004) 1.83
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81
Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus. J Biol Chem (2005) 1.78
Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A (2011) 1.77
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70
Replication and transmission of influenza viruses in Japanese quail. Virology (2003) 1.64
Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS One (2008) 1.63
Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol (2003) 1.62
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Controlling influenza virus replication by inhibiting its proton channel. Mol Biosyst (2006) 1.58
Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol (2004) 1.58
Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol (2009) 1.56
Virology: a class act. Nature (2004) 1.54
Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol (2011) 1.54
Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol (2002) 1.51
A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol (2007) 1.50
Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry (2009) 1.47
Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci U S A (2004) 1.41
Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology (2008) 1.40
Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol (2010) 1.38
The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus. Structure (2008) 1.38
Influenza virus assembly and budding at the viral budozone. Adv Virus Res (2005) 1.37
Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J Am Chem Soc (2011) 1.37
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology (2003) 1.34
Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci U S A (2012) 1.34
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A (2013) 1.34
Structure of the ulster strain newcastle disease virus hemagglutinin-neuraminidase reveals auto-inhibitory interactions associated with low virulence. PLoS Pathog (2012) 1.30
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci U S A (2012) 1.30
An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc Natl Acad Sci U S A (2009) 1.30
Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology (2010) 1.29
Avian influenza virus isolated in wild waterfowl in Argentina: evidence of a potentially unique phylogenetic lineage in South America. Virology (2008) 1.26
Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state. J Virol (2004) 1.24
Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology (2003) 1.24
Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains. PLoS Pathog (2013) 1.22
Evidence of reassortment of pandemic H1N1 influenza virus in swine in Argentina: are we facing the expansion of potential epicenters of influenza emergence? Influenza Other Respir Viruses (2011) 1.21
Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem (2008) 1.20
Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr (2009) 1.19
A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J Virol (2010) 1.18
Influenza virus proton channels. Photochem Photobiol Sci (2006) 1.16
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology (2007) 1.16
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J Gen Virol (2010) 1.16
Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J Mol Biol (2008) 1.16
Expression and initial structural insights from solid-state NMR of the M2 proton channel from influenza A virus. Biochemistry (2002) 1.16
Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol (2013) 1.15
Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis. J Virol (2004) 1.15
Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins. Virology (2007) 1.13
Characterization of influenza virus sialic acid receptors in minor poultry species. Virol J (2010) 1.13
Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc Natl Acad Sci U S A (2011) 1.12
Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat Struct Mol Biol (2012) 1.11
Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain. PLoS Pathog (2013) 1.10
Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol (2010) 1.09
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol (2009) 1.08
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One (2009) 1.08